password
username
Sponsored by CakeMail, an email marketing software.
Newsletter preview


March 03, 2008

Table of Contents

LATEST SUMMARIES

CORPORATION & ENTERPRISE LAW, CRIMINAL LAW & PROCEDURE, TAX LAW, WHITE COLLAR CRIME
• Boulware v. US

ADMINISTRATIVE LAW, CIVIL PROCEDURE, DRUGS & BIOTECH, HEALTH LAW, INJURY AND TORT LAW, PER CURIAM, PRODUCT LIABILITY
• Warner-Lambert Co. v. Kent

You May FREELY Redistribute This E-Mail in Whole
To view the full-text of cases you must sign in to FindLaw.com.

LATEST SUMMARIES

CORPORATION & ENTERPRISE LAW, CRIMINAL LAW & PROCEDURE, TAX LAW, WHITE COLLAR CRIME
Boulware v. US, No. 06-1509
In the context of sections of the Internal Revenue Code that set the conditions for treating certain corporate distributions as returns of capital, nontaxable to the recipient, a distributee accused of criminal tax evasion may claim return-of-capital treatment without producing evidence that either he or the corporation intended a return of capital when the distribution occurred. Read more...

Related Resources
Case Docket for Boulware v. US

ADMINISTRATIVE LAW, CIVIL PROCEDURE, DRUGS & BIOTECH, HEALTH LAW, INJURY AND TORT LAW, PER CURIAM, PRODUCT LIABILITY
Warner-Lambert Co. v. Kent, No. 06–1498
In a one-line, per curiam opinion, the judgment below is affirmed by an equally divided Court. In a case involving Michigan legislation which immunized drugmakers from products liability claims so long as the FDA approved the pharmaceutical product at issue, the circuit court had held that a fraud exception to the immunity legislation was not prohibited through federal preemption. Read more...


You are currently subscribed to ussc-caselaw as: kallyorama@gmail.com .
To manage your newsletter accounts go to: http://newsletters.findlaw.com/nl/sub/review-account.jsp
or to ***, send a blank email to leave-3119133-1395321.92302aeb229352f56508c05e61ca3cc8@info.legalminds.org